This mechanism is different from the previous regulatory mechanism of the NF‐κB pathway, revealing a new way for E. coli to stimulate the activation of the NF‐κB pathway in ICC cells and tumor progression. This evidence concerns the gene NFKB1 and intrahepatic cholangiocarcinoma.